Equities

Metlifecare Ltd

Metlifecare Ltd

Actions
Health CareHealth Care Equipment & Services
  • Price (NZD)4.36
  • Today's Change-0.04 / -0.91%
  • Shares traded149.56k
  • 1 Year change-30.24%
  • Beta1.0758
Data delayed at least 20 minutes, as of Aug 26 2019 01:39 BST.
More ▼

Events & Activity

  • MET:NZC price moved over +1.37% to 4.43
  • MET:NZC price falls below 50-day moving average to 4.36 at 13:32 BST
  • MET:NZC trading volume exceeds daily average by +37.87%
  • MET:NZC price falls below 15-day moving average to 4.37 at 12:48 BST

Key statistics

As of last trade Metlifecare Ltd (MET:NZC) traded at 4.36, 3.81% above its 52-week low of 4.20, set on Aug 06, 2019.
52-week range
Today
4.20Aug 06 20196.51Sep 26 2018
Markit short selling activity
Low
Med
High
Open4.39
High4.40
Low4.36
Bid4.32
Offer4.36
Previous close4.40
Average volume139.19k
Shares outstanding213.30m
Free float167.65m
P/E (TTM)10.04
Market cap938.54m NZD
EPS (TTM)0.4381
NZD
Annual div (ADY)0.105
NZD
Annual div yield (ADY)2.39%
Div ex-dateMar 14 2019
Div pay-dateMar 22 2019
Data delayed at least 20 minutes, as of Aug 26 2019 01:39 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.